Pilot study of high dose fenretinide and vitamin A supplementation in bladder cancer
- 31 December 1994
- journal article
- other
- Published by Elsevier in European Journal Of Cancer
- Vol. 30 (12) , 1909-1910
- https://doi.org/10.1016/0959-8049(94)00336-4
Abstract
No abstract availableThis publication has 8 references indexed in Scilit:
- Phase IIa Study of Fenretinide in Superficial Bladder Cancer, Using DNA Flow Cytometry as an Intermediate End PointJNCI Journal of the National Cancer Institute, 1994
- Retinoids, breast cancer and NK cellsBritish Journal of Cancer, 1993
- Ocular Toxic Effects of FenretinideJNCI Journal of the National Cancer Institute, 1990
- Retinoid Chemoprevention Timing and Dose IntensityCancer Investigation, 1989
- Effects of Retinoids on Macrophage Function and IL-1 ActivityJournal of Leukocyte Biology, 1988
- Urothelial Atypia and Survival Rate of 500 Unselected Patients with Primary Transitional-Cell Tumour of the Urinary BladderScandinavian Journal of Urology and Nephrology, 1988
- Visual and cutaneous toxicity which occurs during N-(4-hydroxyphenyl) retinamide therapy for psoriasisClinical and Experimental Dermatology, 1986
- Abnormal Retinal Function Associated With Fenretinide, a Synthetic RetinoidArchives of Ophthalmology (1950), 1986